## PBJ3: Evolution of antibody immunity to SARS-CoV-2
Then we switch to the good part of immunity – antibody responses by B cells. We will mainly discuss how B cell maturation facilitate spike-specific antibodies against SARS-CoV-2 and touch on the evolution of SAS-CoV-2 variants and how Omicron escapes antibody surveillance.

### Readings
- [Fast-spreading COVID variant can elude immune responses](https://www.nature.com/articles/d41586- 021-00121-z?utm_source=coronapod&utm_medium=podcast&utm_campaign=shownotes)
- [Gruell, H. et al. Antibody-mediated neutralization of SARS-CoV-2. Immunity 55, 925–944 (2022)](https://www.sciencedirect.com/science/article/abs/pii/S1074761322002254)
- Cevik, M., Grubaugh, N. D., Iwasaki, A. & Openshaw, P. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants. Cell 184, 5077–5081 (2021)
- Hastie, K. M. et al. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science 374, 472–478 (2021).
- Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639–644 (2021).
- Scheid, J. F. et al. B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell 184, 3205-3221.e24 (2021).

### Mindmap
